review · 2019 · en
Treatment of Central Precocious Puberty
Eugster E A
Journal of the Endocrine Society
Evidencia · AltaOpen Access
Síntesis
State-of-the-art review of central precocious puberty pharmacotherapy: short- and long-acting GnRH agonists, histrelin implant, and limited indications for adjunctive growth hormone.
Etapas
3-6, 6-12
Dominios
endocrine, puberty
Tags
precocious-puberty · GnRH-agonist · histrelin · leuprolide · Eugster
Afirmaciones que citan esta fuente (1)
clm-gnrh-precocious-puberty
Long-acting GnRH analogs are first-line therapy for central precocious puberty with progression and predicted adult-height compromise; evidence for psychosocial-only indications and idiopathic short stature is limited.